Syndecan-1 expression is induced in the stroma of invasive breast carcinomas in some cases [155], whereas other studies linked an unfavorable prognosis in breast carcinoma patients with syndecan-1 in tumor cells but a better prognosis for those lacking syndecan-1 expression within the stroma. Here, SDC1 is linked to breast carcinoma.